ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mitsuhiro Hachida
Donald L. Morton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hachida, M.
Right arrow Articles by Morton, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hachida, M.
Right arrow Articles by Morton, D. L.

Ann Thorac Surg 1988;45:643-646
© 1988 The Society of Thoracic Surgeons


Articles

A Comparison of Solutions for Lung Preservation Using Pulmonary Alveolar Type II Cell Viability

Mitsuhiro Hachida, M.D.*, Dave S.B. Hoon, Ph.D., Donald L. Morton, M.D.

Division of Surgical Oncology, Department of Surgery, UCLA School of Medicine, Los Angeles, CA

Accepted for publication December 29, 1987.

* Address reprint requests to Dr. Hachida, Division of Surgical Oncology, 9th Floor, Louis Factor Bldg, UCLA School of Medicine, Los Angeles, CA 90024

Many special solutions have been developed to protect the ischemic lung in preparation for transplantation. To determine an effective solution, we isolated pulmonary alveolar type II cells from rat lungs. These cells play an important role in sodium transport and the production of surfactant; thus, they are crucial to the respiratory physiology of the lung. In this study, we examined in vitro the effect of various solutions such as Collins' solution, Collins-Sacks solution, and glucose-insulin-potassium solution on alveolar type II cell viability. The cell viability was examined with a trypan blue dye exclusion test and [3H]thymidine uptake proliferation assay after 24 and 72 hours of incubation. The alveolar type II cells in the glucose-insulin-potassium solution had greater viability compared with cells cultured in either Collins' or Collins-Sacks solution. This study demonstrates that glucose-insulin-potassium solution has the least toxic effect on isolated alveolar type II cells compared with other preserving solutions.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
Y. Liu, Q. Wang, X. Zhu, D. Liu, S. Pan, Y. Ruan, and Y. Li
Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass
Ann. Thorac. Surg., May 1, 2000; 69(5): 1402 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. C. King, O. A. R. Binns, R. C. Kanithanon, P. E. Parrino, T. B. Reece, J. D. Maliszewskyj, K. S. Shockey, C. G. Tribble, and I. L. Kron
Acellular Low-Potassium Dextran Preserves Pulmonary Function After 48 Hours of Ischemia
Ann. Thorac. Surg., September 1, 1997; 64(3): 795 - 800.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. A. R. Binns, N. F. DeLima, S. A. Buchanan, J. T. Cope, R. C. King, C. A. Marek, K. S. Shockey, C. G. Tribble, and I. L. Kron
BOTH BLOOD AND CRYSTALLOID-BASED EXTRACELLULAR SOLUTIONS ARE SUPERIOR TO INTRACELLULAR SOLUTIONS FOR LUNG PRESERVATION
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1515 - 1521.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. J. Serrick, A. Jamjoum, A. Reis, A. Giaid, and H. Shennib
AMELIORATION OF PULMONARY ALLOGRAFT INJURY BY ADMINISTERING A SECOND RINSE SOLUTION
J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1010 - 1016.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Struber, J. Cremer, W. Harringer, S. W. Hirt, A. Costard-Jackle, and A. Haverich
NEBULIZED SYNTHETIC SURFACTANT IN REPERFUSION INJURY AFTER SINGLE LUNG TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 563 - 564.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
P. O. Kimblad and S. Steen
Eliminating the strong pulmonary vasoconstriction caused by euro-collins solution
Ann. Thorac. Surg., September 1, 1994; 58(3): 728 - 733.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. A. Killinger, D. B. Dorofi, E. A. Tinsley, B. A. Keagy, and G. Johnson
Flow cytometric analysis of organ preservation-induced endothelial cell membrane damage
Ann. Thorac. Surg., March 1, 1992; 53(3): 472 - 476.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The Society of Thoracic Surgeons.